Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Kevin Caliendo
UBS

Kevin Caliendo

UBS
Wall Street Analyst
★★★★☆
#402
on 13Foresight · ranked by our own returns
67%
Success Rate
+6.3%
Average Return
53 of 79 calls profitable · +26.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 67% of Kevin Caliendo's ratings turned a profit when each position was held for 1 year — averaging +6.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

48 Buy 38 Hold 0 Sell
Kevin's Stock Coverage 39 ratings · 2026-11-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ICLR
Icon
 Oct 29, 2026 HOLD Strong Buy
-1.8% avg upside
28 analysts
$236.00
11.59% Upside
 -7.0% ·
LH
Labcorp Holdings
 Oct 29, 2026 BUY Strong Buy
-21.6% avg upside
38 analysts
$420.00
16.15% Upside
 +1.1% ·
IQV
IQVIA Holdings
 Oct 28, 2026 BUY Strong Buy
-2.5% avg upside
40 analysts
$345.00
28.97% Upside
 -2.8% ·
MEDP
Medpace Holdings
 Oct 23, 2026 HOLD Buy
-17.3% avg upside
18 analysts
$700.00
7.34% Upside
 -2.0% ·
FTRE
Fortrea Holdings Inc.
 Oct 20, 2026 HOLD Buy
+8.3% avg upside
13 analysts
$24.00
12.81% Upside
 -8.6% ·
SDGR
Schrodinger
 Oct 20, 2026 HOLD Strong Buy
+7.1% avg upside
16 analysts
$21.00
22.66% Downside
 +27.7% ·
DGX
Quest Diagnostics
 Oct 19, 2026 HOLD Buy
-26.4% avg upside
34 analysts
$250.00
0.64% Downside
 +10.0% ·
CAH
Cardinal Health
 Oct 16, 2026 BUY Strong Buy
-14.3% avg upside
30 analysts
$295.00
17.67% Upside
 +9.5% ·
MCK
McKesson
 Oct 16, 2026 BUY Strong Buy
-20.4% avg upside
29 analysts
$1200.00
20.61% Upside
 +6.7% ·
COR
Cencora
 Oct 16, 2026 BUY Buy
-2.6% avg upside
45 analysts
$400.00
20.89% Upside
 +1.4% ·
CERT
Certara
 Oct 02, 2026 HOLD Buy
+21.4% avg upside
23 analysts
$10.00
9.33% Downside
 +25.3% ·
CRL
Charles River Labs
 Sep 30, 2026 BUY Strong Buy
-28.5% avg upside
36 analysts
$357.00
0.75% Downside
 +13.0% ·
MDLN
Medline
 Sep 25, 2026 BUY Strong Buy
+43.4% avg upside
27 analysts
$43.00
33.79% Upside
 +15.2% ·
NVST
Envista Holdings
 Sep 18, 2026 HOLD Buy
+27.4% avg upside
19 analysts
$27.00
14.93% Upside
 +9.2% ·
CVS
CVS Health
 Sep 03, 2026 BUY Strong Buy
+19.5% avg upside
39 analysts
$118.00
30.70% Upside
 -7.2% ·
AHCO
AdaptHealth
 Aug 24, 2026 BUY Strong Buy
+106.2% avg upside
13 analysts
$10.00
72.17% Upside
 +37.1% ·
ACH
Accendra Health
 Aug 13, 2026 HOLD Sell
+6789.2% avg upside
17 analysts
$1.50
490.01% Upside
 -81.8% ·
GDRX
GoodRx Holdings
 Aug 13, 2026 HOLD Buy
+270.4% avg upside
28 analysts
$3.75
7.46% Upside
 -4.8% ·
HSIC
Henry Schein
 Aug 05, 2026 HOLD Buy
+9.6% avg upside
25 analysts
$94.00
10.80% Upside
 -1.3% ·
WAY
Waystar Holding Corp.
 Jul 30, 2026 BUY Strong Buy
+35.0% avg upside
30 analysts
$33.00
17.91% Upside
 +36.1% ·
ALGN
Align Tech
 Jul 23, 2026 HOLD Buy
+89.9% avg upside
21 analysts
$189.00
26.17% Upside
 +0.1% ·
TDOC
Teladoc
 May 15, 2026 HOLD Buy
+241.7% avg upside
38 analysts
$6.00
29.45% Downside
 +39.0% ·
LFST
Lifestance Health Group
 May 08, 2026 BUY Strong Buy
-8.2% avg upside
15 analysts
$13.00
3.03% Downside
 +90.1% ·
EVH
Evolent Health
 May 08, 2026 BUY Strong Buy
+125.9% avg upside
19 analysts
$5.00
16.36% Upside
 +13.2% ·
XRAY
DENTSPLY SIRONA
 May 07, 2026 BUY Buy
+182.3% avg upside
25 analysts
$17.00
78.29% Upside
 -13.9% ·
SOLV
Solventum Corporation
 May 06, 2026 HOLD Buy
+12.8% avg upside
16 analysts
$78.00
4.16% Downside
 +21.4% ·
CI
Cigna
 Feb 09, 2026 BUY Strong Buy
+15.7% avg upside
30 analysts
$375.00
25.70% Upside
 +4.1% ·
ALHC
Alignment Healthcare
 Oct 31, 2025 HOLD Buy
+109.7% avg upside
20 analysts
$18.00
147.66% Upside
 -56.9% ·
MOH
Molina Healthcare
 Jul 25, 2025 HOLD Buy
+16.5% avg upside
26 analysts
$180.00
12.09% Downside
 +19.7% ·
AMWL
American Well
 May 08, 2025 HOLD Hold
+26.4% avg upside
15 analysts
$9.00
29.26% Downside
 +14.5% ·
HUM
Humana
 Feb 24, 2025 HOLD Strong Buy
+5.9% avg upside
34 analysts
$285.00
31.24% Downside
 -30.6% ·
CNC
Centene
 Dec 21, 2023 HOLD Buy
+7.4% avg upside
29 analysts
$79.00
15.44% Upside
 -18.8% ·
UNH
UnitedHealth
 Oct 16, 2023 BUY Strong Buy
+12.6% avg upside
36 analysts
$640.00
57.34% Upside
 +7.8% ·
SDCCQ
SmileDirectClub
 Dec 08, 2022 HOLD Sell
+513999900.0% avg upside
10 analysts
$0.50
49999899.99% Upside
 · ·
ELV
Elevance Health
 Oct 24, 2022 BUY Strong Buy
+10.7% avg upside
33 analysts
$610.00
45.27% Upside
 -13.0% ·
JNJ
Johnson & Johnson
 Oct 03, 2022 HOLD Strong Buy
-9.1% avg upside
40 analysts
$175.00
36.04% Downside
 -2.1% ·
NL:LIGHT
Signify NV
 Mar 09, 2022 BUY Buy
+87.7% avg upside
13 analysts
 — -16.4% ·
MDRX
Veradigm
 Mar 03, 2020 HOLD Buy
+196.2% avg upside
22 analysts
$8.00
60.02% Upside
 +105.5% ·
UAL
United Airlines Holdings
 Jan 30, 2018 BUY Strong Buy
+23.7% avg upside
31 analysts
 — +30.5% ·
🔒 34 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Kevin Caliendo — Frequently Asked Questions
How accurate are Kevin Caliendo's stock ratings?
Based on the calls 13Foresight could measure, about 66% of Kevin's ratings were profitable over a one-year hold, with an average return of +6.7% per rating, or +3.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Kevin ranked on 13Foresight?
Kevin Caliendo is currently ranked #402 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Kevin cover?
Kevin most recently has ratings on ICLR, LH, IQV, MEDP, FTRE, SDGR, DGX, CAH, MCK, COR, CERT, CRL and 27 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.